Fish oil supplements in New Zealand are highly oxidised and do not meet label content of n-3 PUFA

Citations Over TimeTop 1% of 2015 papers

Abstract

Abstract We evaluated the quality and content of fish oil supplements in New Zealand. All encapsulated fish oil supplements marketed in New Zealand were eligible for inclusion. Fatty acid content was measured by gas chromatography. Peroxide values (PV) and anisidine values (AV) were measured and total oxidation values (Totox) calculated. Only 3 of 32 fish oil supplements contained quantities of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) that were equal or higher than labelled content, with most products tested (69%) containing <67%. The vast majority of supplements exceeded recommended levels of oxidation markers. 83% products exceeded the recommended PV levels, 25% exceeded AV thresholds and 50% exceeded recommended Totox levels. Only 8% met the international recommendations, not exceeding any of these indices. Almost all fish oil supplements available in the New Zealand market contain concentrations of EPA and DHA considerably lower than claimed by labels. Importantly, the majority of supplements tested exceeded the recommended indices of oxidative markers. Surprisingly, best-before date, cost, country of origin and exclusivity were all poor markers of supplement quality.

Related Papers

• → The Use of Low-EPA Fish Oil for Long-Chain Polyunsaturated Fatty Acid Supplementation of Preterm Infants(2000)38 cited
• → Fish oil/lycopene microcapsules as a source of eicosapentaenoic and docosahexaenoic acids: a case study on spreads(2019)12 cited
• → CONTRIBUTION OF MICROENCAPSULATED N-3 PUFA POWDER TOWARD SENSORY AND OXIDATIVE STABILITY OF BREAD(2011)24 cited
• → Omega-3 Fatty Acid and its Protective Effect against Cancer and Cancer-related Complication(2022)9 cited
• → Fish Oil: Getting to the Heart of It(2007)14 cited